0001209191-14-040171.txt : 20140624
0001209191-14-040171.hdr.sgml : 20140624
20140610161355
ACCESSION NUMBER: 0001209191-14-040171
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20140609
FILED AS OF DATE: 20140610
DATE AS OF CHANGE: 20140610
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Endo International plc
CENTRAL INDEX KEY: 0001593034
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25-28 NORTH WALL QUAY
CITY: DUBLIN
STATE: L2
ZIP: 1
BUSINESS PHONE: 416-216-0000
MAIL ADDRESS:
STREET 1: 25-28 NORTH WALL QUAY
CITY: DUBLIN
STATE: L2
ZIP: 1
FORMER COMPANY:
FORMER CONFORMED NAME: Endo International Ltd
DATE OF NAME CHANGE: 20131203
FORMER COMPANY:
FORMER CONFORMED NAME: Sportwell Ltd
DATE OF NAME CHANGE: 20131126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DELUCCA JOHN
CENTRAL INDEX KEY: 0001263102
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36326
FILM NUMBER: 14902247
MAIL ADDRESS:
STREET 1: C/O ENZO BIOCHEM INC
STREET 2: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-06-09
0
0001593034
Endo International plc
ENDP
0001263102
DELUCCA JOHN
C/O ENDO INTERNATIONAL PLC
33 FITZWILLIAM SQUARE
DUBLIN
L2
2
IRELAND
1
0
0
0
Ordinary Shares
2014-06-09
4
M
0
6764
24.63
A
34875
D
Ordinary Shares
2014-06-09
4
S
0
6764
68.83
D
28111
D
2007 Stock Incentive Plan Stock Options (NQ)
24.63
2014-06-09
4
M
0
6764
0.00
D
2018-03-12
Ordinary Shares
6764
0
D
On March 10, 2014, in connection with his personal financial planning, Mr. Delucca placed 25,242 of the shares underlying his stock options into a 10b5-1 pre-set selling program (the "Delucca Pre-Set Selling Program"). The options exercised and the shares sold above were sold pursuant to the Delucca Pre-Set Selling Program, which leaves no remaining shares (underlying options) in the current Delucca Pre-Set Selling Program.
This represents the average price at which Mr. Delucca's ordinary shares were sold on June 9, 2014.
Mr. Delucca's stock options that were granted under the 2007 Stock Incentive Plan on March 12, 2008 were generally exercisable 25% per year on each of March 12, 2009, March 12, 2010, March 12, 2011, and March 12, 2012.
These securities were granted to Mr. Delucca in 2008 in consideration of his services on the Endo Health Solutions Inc. Board of Directors.
/s/ Caroline B. Manogue, by Power of Attorney
2014-06-10
EX-24.4_526932
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
Know all by these present that the undersigned hereby makes, constitutes and
appoints Caroline B. Manogue, Daniel A. Rudio, Richard Casten and Justin Dailey
as the undersigned's true and lawful attorneys-in-fact, with full power and
authority as hereinafter described on behalf of and in the name, place and stead
of each of the undersigned to:
(1) prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5 (including
any amendments thereto) with respect to the securities of Endo International
plc, an Irish public limited company (the "Company"), with the United States
Securities and Exchange Commission, any national securities exchanges and the
Company, as considered necessary or advisable under Section 16(a) of the
Securities Exchange Act of 1934 and the rules and regulations promulgated
thereunder, as amended from time to time (the "Exchange Act");
(2) seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information on transactions in the Company's securities from any third
party, including brokers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such person to release any such
information to the undersigned and approves and ratifies any such release of
information; and
(3) perform any and all other acts which in the discretion of such
attorney-in-fact are necessary or desirable for and on behalf of the undersigned
in connection with the foregoing.
The undersigned acknowledges that:
(1) this Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in their discretion on information provided to such
attorney-in-fact without independent verification of such information;
(2) any documents prepared and/or executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney will be in such form and will
contain such information and disclosure as such attorney-in-fact, in his or her
discretion, deems necessary or desirable;
(3) neither the Company nor such attorney-in-fact assumes (i) any liability for
the undersigned's responsibility to comply with the requirement of the Exchange
Act, (ii) any liability of the undersigned for any failure to comply with such
requirements, or (iii) any obligation or liability of the undersigned for profit
disgorgement under Section 16(b) of the Exchange Act; and
(4) this Power of Attorney does not relieve the undersigned from responsibility
for compliance with the undersigned's obligations under the Exchange Act,
including without limitation the reporting requirements under Section 16 of the
Exchange Act.
The undersigned hereby gives and grants the foregoing attorney-in-fact full
power and authority to do and perform all and every act and thing whatsoever
requisite, necessary or appropriate to be done in and about the foregoing
matters as fully to all intents and purposes as the undersigned might or could
do if present, hereby ratifying all that such attorney-in-fact of, for and on
behalf of the undersigned, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney.
This Power of Attorney shall remain in full force and effect with respect to
each undersigned until revoked by such undersigned in a signed writing delivered
to such attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 29th day of April 2014.
SIGNATURE TITLE
/s/ John J. Delucca Director
John J. Delucca
COUNTRY:
On this 29th day of April 2014, the above-named individual personally appeared
before me, and acknowledged that he executed the foregoing instrument for the
purposes therein contained.
IN WITNESS WHEREOF, I have hereunto set my hand and official seal.
/s/ Mark Ronayne
Notary Public
Mark Ronayne
Notary Public
Commissioned for Life
19 Rathfarnham Road,
Terenure, Dublin 6w
Tel: 00 353 1 4900020
M: 00 353 87 2542664
E: mrnotarypublic@gmail.com
www.notaryoncall.ie